Atrás New approaches of chemical safety assessment discussed between regulatory experts and the researchers of EU-ToxRisk

New approaches of chemical safety assessment discussed between regulatory experts and the researchers of EU-ToxRisk

An international workshop organised by EU-ToxRisk paved the way for a new risk assessment strategy, relying less on animal data, and using multi-dimensional information from many sources in the so-called read-across procedure.
30.05.2019

 

An international workshop, held in Espoo (Fin), close to the headquarters of the European Chemicals Agency (ECHA), paved the way for a new risk assessment strategy, relying less on animal data, and using multi-dimensional information from many sources in the so-called read-across procedure.

The event took place on 21-22 May 2019 and was organised by EU-ToxRisk, in close collaboration with regulatory representatives from several European agencies (ECHA, EFSA, SCCS), US agencies (NTP, EPA), and other organisations (OECD, Health Canada, NIHS Japan).

EU-ToxRisk - An Integrated European 'Flagship' Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century - is a research project receiving funding from the European Union's Horizon 2020 research and innovation programme. Its main goal is to increase confidence in the implementation of non-animal approaches into the regulatory decision-making process for hazard and risk assessment. For this purpose, the project works on the development, evaluation and implementation of animal-free New Approach Methods (NAM) in modern toxicology. GRIB participates on this project, in particular, the PharmacoInformatics group of GRIB is leading the development of computational tools which will facilitate the use of NAM in read accross studies.

One of the most promising new risk assessment strategies is the read-across approach. For read-across, new compounds are assessed by comparison to the toxicological data of other chemicals with similar structural/physicochemical properties. 

Although frequently chosen in regulatory submission dossiers, this method often fails to be accepted by regulatory agencies, as the associated uncertainties, e.g. level of similarity among the compounds on toxicokinetics and toxicodynamics behaviour, are perceived as being too large.

In its first three years, the EU-ToxRisk project has addressed this issue by developing a novel read-across approach, introducing the support of NAM-generated (in silico and in vitro) data for reducing those uncertainties. This was now presented to regulators in the workshop "New Approach Method (NAM)-supported read-across: from case studies to regulatory guidance in safety assessment".

While the strategy was strongly welcomed, this may only be a first step towards implementation: 'Getting the science right is not enough', says Matthias Herzler from the German Federal Institute for Risk Assessment (BfR), who claims that 'a comprehensive and accessible way to telling the "read-across story" should also be explored and standardised in order to convince regulatory assessors that NAM-supported read-across is adequate and reliable'.

There is, hence, an obvious need for an advisory document to help a comprehensive submission process of the NAM-assisted read-across regulatory dossiers.

In line with this objective, the overall aim of the workshop in Espoo was to collect scientific and regulatory expert feedback on various read-across scenarios which will serve as input to a EU-ToxRisk advisory report for NAM-supported read-across.

More information

Multimedia

Categorías:

ODS - Objetivos de desarrollo sostenible:

Els ODS a la UPF

Contact